Q1 2026 saw expanded gross margins and operational stabilization after major maintenance, despite lower revenues and negative earnings. Human Nutrition B2B drove growth, B2C margins improved, and a NOK 144.5 million private placement post-period restored equity and liquidity.Original document: Hofs…
Q1 2026 saw expanded gross margins and operational stabilization after major maintenance, despite lower revenues and negative earnings. Human Nutrition B2B drove growth, B2C margins improved, and a NOK 144.5 million private placement post-period restored equity and liquidity.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
